Drug
Azd8848
Azd8848: highest development phase Phase 1, developed by AstraZeneca. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| AZD8848 NCT01560234 | Phase 1 | Healthy |
| AZD8848 NCT01205867 | Phase 1 | Butyrylcholinesterase Deficiency |
Latest
No recent events.
Follow Azd8848 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.